Schizophrenia Linked With Common Viral Infections
A growing body of research suggests there may be associations between common viral infectious such as Epstein Barr and Toxoplasma gondii and schizophrenia.
Schizophrenia and Psychoses
SCHIZOPHRENIA AND PSYCHOSES
Featured Article
Latest News
Greater EEG Activity in Patients at High Risk for Psychosis Not Associated With Negative Symptoms
There may be no association between functioning and the slow wave power in the frontal region of individuals at ultra-high risk for psychosis.
Cognitive Control in Patients With Mental Illness Differs by Diagnosis
Study findings suggest a continuum of dysfunction in cognitive control across psychiatric illnesses, including bipolar and schizophrenia.
Aripiprazole Not Associated With Increased Hospitalizations, Suicidality in Patients Previously Treated With Antipsychotics
Introducing aripiprazole after previous antipsychotic exposure did not appear to increase serious psychiatric risk.
Depression Associated With Polygenic Risk for Major Depression, Bipolar Disorder, and Schizophrenia
Polygenic risk for major depression, bipolar, and schizophrenia is linked to depression in the general population.
Deviations From Normative Amygdala Connectivity Associated With Psychosis in Youth
A lack of normative development of amygdala connectivity in youths with psychosis spectrum disorders may lead to better understanding of the neural basis of affective impairments in psychosis.
Changes in BMI, Waist-to-Hip Ratio in Never and Minimally Treated Patients With Psychosis
Investigators sought to determine differences in obesity measurements in antipsychotic-naïve and minimally treated patients with psychosis.
Phone Contact Improved Medication Adherence in Severely Mentally Ill Patients
Telemedicine can deliver support to patients who are otherwise at high risk for progressive nonadherence to their psychotropic medication regimens.
Wisdom Linked to Cognitive Performance in Schizophrenia
For people with schizophrenia, wisdom is associated with better cognitive performance.
Early Placebo Improvement May Be a Marker for Long-Term Placebo Response in Schizophrenia Trials
Investigators examine patients who demonstrated improvement after placebo injections and aimed to determine criteria to predict subsequent response.
Guanfacine Augmentation for Cognitive Therapy Effective for Schizotypal Personality Disorder
Augmentation with guanfacine alongside cognitive remediation and social skills may be an effective intervention for patients with schizotypal personality disorder.
Want to read more?
Please login or register first to view this content.
Next post in Schizophrenia and Psychoses